Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis a long-term echocardiographic study.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 19442887)

Published in J Am Coll Cardiol on May 19, 2009

Authors

Francesco Antonini-Canterin1, Elisa Leiballi, Roxana Enache, Bogdan A Popescu, Monica Roşca, Eugenio Cervesato, Rita Piazza, Carmen Ginghină, Gian Luigi Nicolosi

Author Affiliations

1: Cardiologia ARC, Azienda Ospedaliera S. Maria degli Angeli, Pordenone, Italy. cardiologia@aopn.fvg.it

Articles by these authors

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J (2012) 16.00

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2012) 10.38

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.02

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation (2002) 4.56

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 4.10

European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr (2010) 3.70

European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr (2010) 2.25

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol (2010) 1.92

Morphological and functional adaptation of the maternal heart during pregnancy. Circ Cardiovasc Imaging (2012) 1.78

Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging (2013) 1.72

Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial. Eur Heart J (2009) 1.63

Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram. Circ Heart Fail (2012) 1.59

Prognostic value of ventricular-arterial coupling and B-type natriuretic peptide in patients after myocardial infarction: a five-year follow-up study. J Am Soc Echocardiogr (2009) 1.55

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail (2004) 1.53

Impact of aortic stiffness on left ventricular function and B-type natriuretic peptide release in severe aortic stenosis. Eur J Echocardiogr (2011) 1.48

Accuracy of handheld echocardiography for bedside diagnostic evaluation in a tertiary cardiology center: comparison with standard echocardiography. Echocardiography (2010) 1.47

Cardiac structure and function and insulin resistance in morbidly obese patients: does superobesity play an additional role? Cardiology (2013) 1.42

Cardiac resynchronization therapy as an 'alternative' approach to a non-operable severe aortic stenosis with left ventricular dysfunction. J Heart Valve Dis (2006) 1.39

Incremental value of arterial stiffness over traditional risk factors in predicting subclinical cardiovascular remodeling in patients with moderate chronic renal failure. Angiology (2011) 1.39

Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart (2011) 1.11

Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations. Eur Heart J Cardiovasc Imaging (2013) 1.11

Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr (2009) 1.09

Symptomatic aortic stenosis: does systemic hypertension play an additional role? Hypertension (2003) 1.07

Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist's point of view. Eur J Echocardiogr (2008) 1.05

Letter by De Mattia et al regarding article, "Digital clubbing". Circulation (2013) 1.04

Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial. J Cardiovasc Med (Hagerstown) (2006) 1.04

Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail (2005) 1.01

Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol (2003) 1.00

[Focused care in cardiology: is the centrality of the patient or the organization the goal?]. G Ital Cardiol (Rome) (2011) 0.96

Spontaneous closure of postinfarction ventricular septal rupture. A case report. Ital Heart J (2003) 0.95

Left atrial dysfunction as a correlate of heart failure symptoms in hypertrophic cardiomyopathy. J Am Soc Echocardiogr (2010) 0.94

Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol (2008) 0.93

Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging (2015) 0.92

The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging (2015) 0.90

Effect of statins on the progression of bioprosthetic aortic valve degeneration. Am J Cardiol (2003) 0.90

Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial. Eur J Heart Fail (2012) 0.90

Mesenteric ischemia--a complex disease requiring an interdisciplinary approach. A review of the current literature. Rom J Intern Med (2010) 0.89

Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania. Nephrol Dial Transplant (2009) 0.89

Asymptomatic isolated congenital left ventricular muscular diverticulum in an adult: a case report. Echocardiography (2003) 0.88

Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment? Ital Heart J (2005) 0.87

Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer (2010) 0.86

Left atrium remodeling after acute myocardial infarction (results of the GISSI-3 Echo Substudy). Am J Cardiol (2004) 0.85

Report on the European Association of Echocardiography accreditations in echocardiography: December 2003-September 2006. Eur J Echocardiogr (2006) 0.84

Left ventricular torsional dynamics in aortic stenosis: relationship between left ventricular untwisting and filling pressures. A two-dimensional speckle tracking study. Eur J Echocardiogr (2010) 0.84

Dynamic left ventricular outflow tract obstruction in the setting of acute anterior myocardial infarction: a serious and potentially fatal complication? Echocardiography (2002) 0.84

Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age. Rom J Intern Med (2008) 0.83

Right ventricular function predicts clinical response to specific vasodilator therapy in patients with pulmonary hypertension. Echocardiography (2012) 0.83

Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study). Eur Heart J Cardiovasc Imaging (2013) 0.83

CME: long-term outcome in asymptomatic patients with severe aortic regurgitation, normal left ventricular ejection fraction, and severe left ventricular dilatation. Echocardiography (2010) 0.82

Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction. Int J Cardiol (2012) 0.82

Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial. J Cardiovasc Med (Hagerstown) (2007) 0.82

Mechanism of mitral regurgitation in inferior wall acute myocardial infarction. Am J Cardiol (2002) 0.81

Appropriateness criteria for cardiovascular imaging use in clinical practice: a position statement of the ESC/EACVI taskforce. Eur Heart J Cardiovasc Imaging (2014) 0.81

Double-exit transaortic sinus cusp ventricular tachycardia: an unusual form of idiopathic outflow tract tachycardia treated by radiofrequency catheter ablation. Heart Rhythm (2006) 0.80

Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B-type natriuretic peptide. Echocardiography (2007) 0.80

Changes in plasma levels of MMP-9, MMP-7 and their inhibitors in patients with coronary artery disease. Rom J Intern Med (2010) 0.80

[Nutritional status evaluation in maintenance hemodialysis patients]. Rev Med Chir Soc Med Nat Iasi (2009) 0.80

Left ventricular twist dynamics: principles and applications. Heart (2013) 0.80

Images in cardiology. Atrioventricular block in the elderly: does echocardiography hold the key? J Am Coll Cardiol (2011) 0.80

[Not Available]. Turk Kardiyol Dern Ars (2012) 0.79

Are statins effective in preventing bioprosthetic aortic valve failure? A need for a prospective, randomized trial. Ital Heart J (2004) 0.79

Transient platypnea-orthodeoxia-like syndrome induced by propafenone overdose in a young woman with Ebstein's anomaly. Ital Heart J (2003) 0.79

Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement. Int J Cardiol (2007) 0.79

[Two cases of false troponin I increase in patients with heterophile antibodies]. Ital Heart J Suppl (2002) 0.79